PMID- 33045621 OWN - NLM STAT- MEDLINE DCOM- 20210618 LR - 20210618 IS - 2213-2317 (Electronic) IS - 2213-2317 (Linking) VI - 37 DP - 2020 Oct TI - Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1alpha-ERO1alpha-dependent oxidative stress manner. PG - 101742 LID - S2213-2317(20)30947-2 [pii] LID - 10.1016/j.redox.2020.101742 [doi] LID - 101742 AB - Hyperhomocysteinemia (HHcy) is related to liver diseases, such as nonalcoholic fatty liver (NAFL). Although the precise pathogenesis of NAFL is still largely unknown, the links between organs seem to play a vital role. The current study aimed to explore the role of white adipose tissue in homocysteine (Hcy)-induced NAFL. Blood samples from nonhyperhomocysteinemia or hyperhomocysteinemia individuals were collected to assess correlation between Hcy and triglyceride (TG) or free fatty acids (FFAs) levels. C57BL/6 mice were maintained on a high-methionine diet or administered with Hcy (1.8 g/L) in the drinking water to establish an HHcy mouse model. We demonstrated that Hcy activated adipocyte lipolysis and that this change was accompanied by an increased release of FFAs and glycerol. Excessive FFAs were taken up by hepatocyte, which resulted in lipid accumulation in the liver. Treatment with acipimox (0.08 g kg (-1) day (-1)), a potent chemical inhibitor of lipolysis, markedly decreased Hcy-induced NAFL. Mechanistically, hypoxia-inducible factor 1alpha (HIF1alpha)-endoplasmic reticulum oxidoreductin 1alpha (ERO1alpha) mediated pathway promoted H(2)O(2) accumulation and induced endoplasmic reticulum (ER) overoxidation, ER stress and more closed ER-lipid droplet interactions, which were responsible for activating the lipolytic response. In conclusion, this study reveals that Hcy activates adipocyte lipolysis and suggests the potential utility of targeted ER redox homeostasis for treating Hcy-induced NAFL. CI - Copyright (c) 2020 The Author(s). Published by Elsevier B.V. All rights reserved. FAU - Yan, Yu AU - Yan Y AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. FAU - Wu, Xun AU - Wu X AD - National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, PR China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, PR China. FAU - Wang, Pengcheng AU - Wang P AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. FAU - Zhang, Songyang AU - Zhang S AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. FAU - Sun, Lulu AU - Sun L AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. FAU - Zhao, Yang AU - Zhao Y AD - Department of Laboratory Medicine, Peking University Third Hospital, Beijing, 100191, PR China. FAU - Zeng, GuangYi AU - Zeng G AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. FAU - Liu, Bo AU - Liu B AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. FAU - Xu, Guoheng AU - Xu G AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. FAU - Liu, Huiying AU - Liu H AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. FAU - Wang, Lei AU - Wang L AD - National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, PR China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, PR China. Electronic address: wanglei@ibp.ac.cn. FAU - Wang, Xian AU - Wang X AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China. Electronic address: xwang@bjmu.edu.cn. FAU - Jiang, Changtao AU - Jiang C AD - Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing, 100191, PR China; Center of Basic Medical Research, Institute of Medical Innovation and Research, Third Hospital, Peking University, Beijing, 100191, PR China; Center for Obesity and Metabolic Disease Research, School of Basic Medical Sciences, Peking University, Beijing, 100191, PR China. Electronic address: jiangchangtao@bjmu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20201001 PL - Netherlands TA - Redox Biol JT - Redox biology JID - 101605639 RN - 0LVT1QZ0BA (Homocysteine) RN - BBX060AN9V (Hydrogen Peroxide) SB - IM MH - Adipocytes MH - Animals MH - Endoplasmic Reticulum Stress MH - *Homocysteine MH - Hydrogen Peroxide MH - *Lipolysis MH - Mice MH - Mice, Inbred C57BL MH - Oxidative Stress PMC - PMC7559542 OTO - NOTNLM OT - Adipocyte lipolysis OT - ER oxidoreductin 1alpha OT - Hyperhomocysteinemia OT - Hypoxia-inducible factor 1alpha OT - Nonalcoholic fatty liver COIS- The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: EDAT- 2020/10/13 06:00 MHDA- 2021/06/22 06:00 PMCR- 2020/10/01 CRDT- 2020/10/12 20:13 PHST- 2020/01/20 00:00 [received] PHST- 2020/09/25 00:00 [revised] PHST- 2020/09/28 00:00 [accepted] PHST- 2020/10/13 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2020/10/12 20:13 [entrez] PHST- 2020/10/01 00:00 [pmc-release] AID - S2213-2317(20)30947-2 [pii] AID - 101742 [pii] AID - 10.1016/j.redox.2020.101742 [doi] PST - ppublish SO - Redox Biol. 2020 Oct;37:101742. doi: 10.1016/j.redox.2020.101742. Epub 2020 Oct 1.